10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
Has Torex Gold Resources Inc.'s (TSE:TXG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Most readers would already be aware that Torex Gold Resources' (TSE:TXG) stock increased significantly by 33% over ...
2 Reasons to Sell TXG and 1 Stock to Buy Instead
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...
Nasdaq21d
Insider Sale: Chief Executive Officer of $TXG Sells 7,942 Shares
Serge Saxonov, the Chief Executive Officer of $TXG, sold 7,942 shares of the company on 02-28-2025 for an estimated $84,393. We received data on the trade from a ...
Nasdaq28d
Insider Purchase: Director at $TXG Buys 40,000 Shares
ALAN MATEO, a director at $TXG, bought 40,000 shares of the company on 02-21-2025 for an estimated $445,572. This trade was reported by Quiver Quantitative using data ...
StockStory.org on MSN17d
1 Stock Under $50 on Our Watchlist and 2 to Ignore
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some ...
Investing8d
10X Genomics Inc (TXG)
In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week ...